Significant gaps remain, particularly the lack of treatments with adequate safety and true disease-modifying potential capable of addressing key pathological drivers such as neuroinflammation, mitochondrial dysfunction, impaired proteostasis and toxic protein aggregation (Jiang et al., 2025)
PubMed record Kannengiesser K, Maaser C, Heidemann J, et al
While the cost of GLP-1 coverage is top of mind for employers right now, they should not forget to factor in the significant cost of obesity-related complications, said Elina Onitskansky, the founder and CEO of obesity treatment company Ilant Health
How concerned should I be
This enzyme is able to convert the superoxide anion into hydrogen peroxide (H 2 O 2 )
Maintaining this temperature range preserves the peptide structure and prevents degradation that could reduce medication potency